675
Participants
Start Date
September 16, 2012
Primary Completion Date
May 4, 2017
Study Completion Date
May 4, 2017
AIN457 150 mg
(1 injection per dose) and placebo to Secukinumab 150 mg
AIN457 300 mg
Secukinumab 150 mg (2 injections per dose)
Placebo
Novartis Investigative Site, Hanoi
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Bern
Novartis Investigative Site, Wels
Novartis Investigative Site, Pleven
Novartis Investigative Site, Ho Chi Minh City
Novartis Investigative Site, Zurich
Novartis Investigative Site, Varna
Novartis Investigative Site, Mahlow
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Buchholz I. D. Nordheide
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Winston-Salem
Novartis Investigative Site, High Point
Novartis Investigative Site, Greensboro
Novartis Investigative Site, Anderson
Novartis Investigative Site, Greer
Novartis Investigative Site, Atlanta
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Jacksonville
Novartis Investigative Site, Jacksonville
Novartis Investigative Site, Miami
Novartis Investigative Site, South Miami
Novartis Investigative Site, West Palm Beach
Novartis Investigative Site, Verona
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Bochum
Novartis Investigative Site, Essen
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Duisburg
Novartis Investigative Site, Münster
Novartis Investigative Site, Cologne
Novartis Investigative Site, Siena
Novartis Investigative Site, Mainz
Novartis Investigative Site, Fridley
Novartis Investigative Site, Skokie
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Champaign
Novartis Investigative Site, St Louis
Novartis Investigative Site, Overland Park
Novartis Investigative Site, Pierre-Bénite
Novartis Investigative Site, Dallas
Novartis Investigative Site, Bad Wildbad
Novartis Investigative Site, Rouen
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Salt Lake City
Novartis Investigative Site, Henderson
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, Pasadena
Novartis Investigative Site, Antony
Novartis Investigative Site, Fresno
Novartis Investigative Site, San Francisco
Novartis Investigative Site, Hanoi
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Ho Chi Minh City
Novartis Investigative Site, Boston
Novartis Investigative Site, Verona
Novartis Investigative Site, Goodlettsville
Novartis Investigative Site, Barrie
Novartis Investigative Site, Oakville
Novartis Investigative Site, Waterloo
Novartis Investigative Site, Windsor
Novartis Investigative Site, Montreal
Novartis Investigative Site, Brno - Bohunice
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Prague
Novartis Investigative Site, České Budějovice
Novartis Investigative Site, Nový Jičín
Novartis Investigative Site, Prague
Novartis Investigative Site, Nice
Novartis Investigative Site, Dippoldiswalde-Schmiedeberg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kisarazu
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Osaka
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Chiyoda-ku
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Itabashi-ku
Novartis Investigative Site, Minato-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Lodz
Novartis Investigative Site, Poznan
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Košice
Novartis Investigative Site, Košice
Novartis Investigative Site, Poprad
Novartis Investigative Site, Svidník
Novartis Investigative Site, Žilina
Novartis Investigative Site, Leytonstone
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Blackpool
Novartis Investigative Site, Leicester
Novartis Investigative Site, Poole
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY